4.8 Meeting Abstract

A pilot study for safety and efficacy of 12 weeks sofosbuvir plus daclatasvir with or without ribavirin in egyptian adolescents with chronic hepatitis C virus Infection

Journal

JOURNAL OF HEPATOLOGY
Volume 66, Issue 1, Pages S178-S178

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S0168-8278(17)30642-6

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available